In Vivo Pharmacodynamics of a New Triazole, Ravuconazole, in a Murine Candidiasis Model

In vivo studies have characterized the pharmacodynamic characteristics of the triazole fluconazole. These investigations demonstrated that the ratio of the area under the concentration-time curve from 0 to 24 h to the MIC (24-h AUC/MIC ratio) is the critical pharmacokinetic/pharmacodynamic (PK/PD) p...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Andes, D., Marchillo, K., Stamstad, T., Conklin, R.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2003
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC152484/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12654646/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.4.1193-1199.2003
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!